| Application no. and date | 15154629.8 (espacenet) (Federated) (European Patent Register), 20150211 | | Patent/reg. no. and date | DK/EP 3056216, 20170201 | | Publication date | 20160817 | | Priority no. and date | | | EP pub. no. and date |
EP 3056216 20160817 | | Effective date | | | Applicant/owner | Deutsches Krebsforschungszentrum, Im Neuenheimer Feld 280
69120 Heidelberg, DE,
Ruprecht-Karls-Universität, Grabengasse 1
69117 Heidelberg, DE | | Applicant ref. no. | P22575DKEP | | Inventor | ROMMELAERE, Jean, Schloss-Wolfsbrunnenweg 11
69118 Heidelberg, DE,
GELETNEKY, Karsten, Beethoven-Str. 35
69121 Heidelberg, DE,
WICK, Wolfgang, Schloss-Wolfsbrunnenweg 1
69117 Heidelberg, DE,
WICK, Antje, Schloss-Wolfsbrunnenweg 1
69117 Heidelberg, DE,
DAHM, Michael, Saalestr. 5
81677 München, DE | | Representative | Patrade A/S, Ceresbyen 75, 8000 Århus C | | Opponent | | | IPC Class | A61K 35/768 (2015.01) , A61K 39/395 (2006.01) , A61P 35/00 (2006.01) , C07K 16/22 (2006.01) | | Title | Kræftbehandling med parvovirus kombineret med bevacizumab | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
